Monsenso signs a new contract with Empano

Monsenso signs a new contract with Empano

by | Jul 18, 2021 | News

Monsenso expands collaboration with Empano, a private provider of psychology and psychiatry services, signing a new contract to help citizens with stress return to work in the municipality of Slagelse.

Monsenso and Empano partnered up last year to help unemployed people get back to work faster. Together, Monsenso and Empano offer a solution for Danish municipalities to help unemployed people suffering from stress and depression return to work.
Following the successful implementation in the municipality of Guldborgssund, the services are now offered to more municipalities, starting in the municipality of Slagelse, Denmark.

Empano offers individual courses and group sessions to the employment sector in the municipalities and uses Monsenso’s digital health solution to collect self-reported data from service users to validate and demonstrate the program’s effectiveness.

The courses have a duration of 6-8 weeks each, after which new citizens are enrolled.

It is a preventative course that teaches strategies to reduce stress and promote mental health. Citizens are introduced to techniques that enable them to better cope with symptoms and challenges in everyday life and the job market, based on cognitive therapy, metacognitive therapy, and mindfulness.

“We are excited to expand our collaboration with Empano to help more people get back to work faster,” says CEO Thomas Lethenborg. “Mental health and unemployment are closely linked. While unemployment can cause stress which may have other negative consequences on people’s mental health, including depression, anxiety and lower self-esteem, a good mental health has shown to have a positive impact on employability, finding a job and staying in that job.”

Monsenso signs a contract with the Elite Sports Academy Aarhus (ESAA)

Monsenso signs a contract with the Elite Sports Academy Aarhus (ESAA)

by | May 19, 2021 | News

Monsenso signs a contract with the Elite Sports Academy Aarhus (ESAA). The Monsenso digital health solution will be used to promote mental wellbeing among ESAA’s students.

Strong mental health is a prerequisite for top athletes to perform at their best. Yet, top athletes are more vulnerable to psychological distress due to the top performance culture. In response, many clubs have over the recent years taken initiatives to promote mental health among their elite athletes and today sports psychology is as much about mental health, as it is about athletic performance.

ESAA, an Elite Sports Academy located in Aarhus (Denmark), is no exception. With mental health as part of the academy’s core values (Mind, Body, Culture, Team), ESAA seeks to provide their young athletes with self-insight and tools to learn how to master the mental aspects of being an elite athlete.

From August 2021, 75 young elite athletes will be offered the Monsenso mhealth app as part of ESAA’s talent program to track their mental wellbeing daily, while giving them access to “Tools” and “Challenges” to boost their mental health and wellbeing. ‘Tools’ provides the young athletes with coping strategies and ‘Challenges’ helps to learn new skills, like how to gain insight into their emotions, how to develop a positive mindset or improve their confidence.

At the same time, the daily tracking offers ESAA the opportunity to identify and act proactively upon signs and symptoms of mental distress, and hereby to provide preventive support to their young athletes.

 “We are pleased to collaborate with ESAA in this project,” says Thomas Lethenborg, CEO of Monsenso. “The importance of mental health in elite sport, in particular among young athletes, can not be underestimated and we are happy that the Monsenso solution can contribute to that. 

For additional information contact:
Bettina van Wylich-Muxoll
Chief Marketing Officer
marketing@monsenso.com
Monsenso

 

 

 

The EcoWeb project has recruited more than 1600 participants across four countries despite COVID-19

The EcoWeb project has recruited more than 1600 participants across four countries despite COVID-19

by | Mar 4, 2021 | News

Since the EcoWeB project launched MyMoodCoach (an app powered by Monsenso) in November 2020 it has recruited more than 1600 young participants in Belgium, UK, Spain and Germany.

The EcoWeB research study, led by Professor Ed Watkins University of Exeter, seeks to understand what influences mood, how emotions change over time, and which emotional skills increase well-being among youth.

The participants are asked to use MyMoodCoach to monitor their emotions in daily life, while giving them access to “Tools” and “Challenges” to boost their mental health and wellbeing. ‘Tools’ provide the participants with strategies to help them if they feel sad, stressed, anxious or have a problem. ‘Challenges’ help them to learn new skills, develop a positive mindset, improve their confidence and gain insight into their emotions.

The strong pick up of MyMoodCoach reflects a desire among youth to take better care of their mental wellbeing.

“We are very pleased to contribute to this project, as young people have been particularly impacted by COVID-19.” says Thomas Lethenborg, CEO of Monsenso. “Mobile health solutions have proved true value during the pandemic, allowing both clinical practice and important research projects to continue despite lockdowns.”

About the project:

The EcoWeB project is led by Professor Ed Watkins, University of Exeter, and involves 13 different institutions across 8 European nations (the UK, Germany, Belgium, Spain, Greece, the Czech Republic, Denmark, and Switzerland). The project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 754657.

About Monsenso digital health solution:
Monsenso is an innovative technology company offering a digital health solution used for decentralised trials, remote patient monitoring and treatment support. Our mission is to contribute to improved health for more people at lower costs by supporting treatment digitally and leveraging patient-reported outcomes data. Our solution helps optimise the treatment and gives a detailed overview of an individual’s health through the collection of outcome, adherence, and behavioural data. It connects individuals, carers, and health care providers to enable personalised treatment, remote care, and early intervention. We collaborate with health and social care, pharmaceuticals, and leading researcher worldwide in our endeavours to deliver solutions that fit into the life of patients and health care professionals. To learn more visit  www.monsenso.com.

BOOK A DEMO
Monsenso signs agreement to support global pharmaceutical across Europe

Monsenso signs agreement to support global pharmaceutical across Europe

by | Aug 22, 2020 | Investor, News

Following a year-long collaboration, Monsenso signs a three-year +10 mio DKK agreement with a global pharmaceutical company.

Monsenso’s mobile health solution will be used for real-world data collection across two studies in connection with the launch of a new drug for depression treatment. The studies are expected to start in the first half of 2021 and will run over a three-year period, covering up to 2250 patients and 120 clinicians across Belgium, the Netherlands, the United Kingdom, Switzerland, Italy, Spain, Denmark, Sweden and France.

In connection with the two studies, Monsenso’s solution will be used to collect data from patients and their relatives through clinical questionnaires, daily self-assessments and behavioral data from smartphones and wearables.

In addition, the patients will be offered in-app study information and can receive reminders about medication and consultations with their clinician. Monsenso’s unique mobile health solution will in this way help increase the quality of clinical studies with real-time data collection while also facilitating better communication between patients, caregivers and clinicians.

“We are very pleased to expand our collaboration with this global pharmaceutical company and to participate in these projects. Depression is a leading burden of disease for society, and it has severe consequences for patients and their family caregivers, so we are proud to contribute to solving this problem” says Thomas Lethenborg, CEO of Monsenso. “In addition, the project will support our European expansion and our focus on partnering with pharmaceuticals, which is in line with our strategy”. 

The project will not affect Monsenso’s previously communicated plans and guidance for the 2020 financial year.

To read the Danish version, click here.

For additional information contact:
Bettina van Wylich-Muxoll
Chief Marketing Officer
marketing@monsenso.com
Monsenso

BOOK A DEMO
Monsenso partners with Australian Mental & Social Health Counselling Service Provider On the Line

Monsenso partners with Australian Mental & Social Health Counselling Service Provider On the Line

by | Dec 19, 2017 | News

Monsenso will partner with On the Line to assist counsellors in helping clients self-manage their anxiety, bipolar disorder, borderline personality disorder, depression, post-traumatic stress disorder and schizophrenia.

Copenhagen, Denmark – 19 December 2017 Monsenso, a Danish company developing mobile health solutions for mental health has partnered with On the Line, an Australian social health business. On the Line offers telephone, web chat and video counselling and social media moderation services 24/7 to more than 80, 000 people each year.

Monsenso’s mHealth solution will act as a proactive self-management app to strengthen the support and connection between counsellors and clients with a wide range of affective  and psychotic disorders. Specifically, the solution will offer a detailed routine monitoring system to help On the Line counsellors access detailed information regarding clients. This information will help counsellors  to support clients to better manage their health.

Clients will be able to input mood level, hours slept, medication taken, exercise, stress and more and this data will be fed into the dashboard to give On the Line counsellors a historic overview and analysis for each client.

“Our mHealth solution is the ideal complement to remote  and outpatient care.” said Thomas Lethenborg, CEO of Monsenso, “The live-time data collection and synchronization between clinician and client can help to enhance the quality of psychotherapeutic counselling.”  

On the Line has more than 55 years of experience in delivering mental health services to the community. It is the national provider of some of Australia’s most vital and trusted services, including MensLine Australia, Suicide Call Back Service and SuicideLine Victoria. On the Line helps encourage people to feel better by building resilience, fostering healthy relationships, and connecting people with community support.

“The Monsenso solution will help counsellors to have a clearer picture of how their clients feel on a daily basis. For our clients, it will help them to manage their condition, identify triggers and warning signs and empower them to better manage their social health and wellbeing.” said Kim O’Neill, CEO at On The Line.

Click on this link to read this press release in Danish.

For additional information contact:

Helen Chen
Marketing
Monsenso
+45 30 25 15 26
chen@monsenso.com